NDC product
Omeprazole and Sodium Bicarbonate
NDC 85509-1032 · PHOENIX RX LLC
Key facts
| Product NDC | 85509-1032 |
|---|---|
| Proprietary name | Omeprazole and Sodium Bicarbonate |
| Nonproprietary name | Omeprazole and Sodium Bicarbonate |
| Substances | OMEPRAZOLE, SODIUM BICARBONATE |
| Dosage form | CAPSULE |
| Route | ORAL |
| Labeler | PHOENIX RX LLC |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Application number | ANDA204228 |
| Pharmacologic classes | Alkalinizing Activity [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA] |
| Marketing start | Jul 30, 2025 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: